Reaction
Fibrocystic Breast Disease reporting signals
As of the last recalculation, Fibrocystic Breast Disease appears in 736 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 80.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 208 | 80.9 | 81.0 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 57 | 73.9 | 74.1 |
| Conjugated Estrogens | 91 | 50.2 | 50.3 |
| Estrogens, Conjugated | 91 | 49.3 | 49.4 |
| Medroxyprogesterone Acetate | 67 | 41.7 | 41.8 |
| Etonogestrel And Ethinyl Estradiol | 31 | 41.2 | 41.3 |
| Raloxifene Hydrochloride | 19 | 37.8 | 37.8 |
| Estradiol | 58 | 20.5 | 20.5 |
| Dolutegravir Sodium | 5 | 15.8 | 15.8 |
| Levonorgestrel | 27 | 3.9 | 3.9 |